GLP-1 Market
LLY $1347.11 ▼ -0.3% NVO $37.82 ▼ -2.7% PFE $27.40 ▼ -0.5% VKTX $24.77 ▼ -4.1% KLRA $11.02 ▼ -4.8% GPCR $16.13 ▼ -5.8% RHHBY $58.46 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

AV-1451

AV-1451

Company
Mayo Clinic
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
13 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

13 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 21, 2026

Find a Clinical Trial Near Me

See recruiting studies for AV-1451 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01818661

    Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

    Not yet reported Mayo Clinic 50 participants Est. completion 2028-06 1 site Stand-alone
    Other conditions: PPA, Non-fluent Aphasia, Apraxia of Speech, Primary Progressive Non-fluent Aphasia, Primary Progressive Aphasia
    View official trial listing →
  • Recruiting NCT NCT02414347

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

    Tammie L. S. Benzinger, MD, PhD 900 participants Est. completion 2026-12 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT02605785

    A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy

    Not yet reported Mayo Clinic 332 participants Est. completion 2030-01 1 site
    Other conditions: Progressive Supranuclear Palsy
    View official trial listing →
  • Recruiting NCT NCT02740634

    Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

    Not yet reported Mayo Clinic 60 participants Est. completion 2027-03 1 site
    Other conditions: Atypical Alzheimer's Disease, Logopenic Progressive Aphasia (LPA), Posterior Cortical Atrophy (PCA), Alzheimer Disease, Alzheimer Disease, Early Onset, Amnestic Disorder, Amnestic Symptoms, Amnestic Mild Cognitive Disorder
    View official trial listing →
  • Recruiting NCT NCT03143374

    PET Tau - Neurodegenerative Disease Imaging

    Not yet reported, Not yet reported University of Pennsylvania 300 participants Est. completion 2030-09 1 site Stand-alone
    Other conditions: Neurodegenerative Disease
    View official trial listing →
  • Recruiting NCT NCT03809351

    UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy

    Not yet reported University of Alabama at Birmingham 160 participants Est. completion 2028-07 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT04150198

    MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 45 participants Est. completion 2029-12-31 2 sites
    Other conditions: Alzheimer Disease, Early Onset, Posterior Cortical Atrophy
    View official trial listing →
  • Recruiting NCT NCT04579120

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

    Tammie L. S. Benzinger, MD, PhD 650 participants Est. completion 2027-12 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT04708613

    University of Pittsburgh Brain Health Initiative

    David Okonkwo, MD, PhD 300 participants Est. completion 2026-12 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT05446805

    Depression and Driving

    Washington University School of Medicine 150 participants Est. completion 2027-12-17 1 site
    Other conditions: Depression, Drive
    View official trial listing →
  • Recruiting NCT NCT05658913

    Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

    University of Pennsylvania 100 participants Est. completion 2029-12 2 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Recruiting NCT NCT06833645

    [18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease

    Sichuan Provincial People's Hospital 280 participants Est. completion 2025-02-25 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Recruiting NCT NCT07000851

    Imaging Studies in Corticobasal Syndrome

    Jennifer Whitwell 80 participants Est. completion 2031-03-30 1 site
    Other conditions: Cortico Basal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration, Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS)
    View official trial listing →
  • Enrolling by invitation NCT NCT00950430

    Imaging of Brain Amyloid Plaques in the Aging Population

    Not yet reported Mayo Clinic 8000 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia, Vascular Dementia
    View official trial listing →
  • Completed NCT NCT01231971

    Alzheimer's Disease Neuroimaging Initiative 2

    University of Southern California 1182 participants Est. completion 2017-11-29 58 sites
    Other conditions: Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD), Significant Memory Concern (SMC), Early Mild Cognitive Impairment (EMCI), Late Mild Cognitive Impairment (LMCI)
    View official trial listing →
  • Completed NCT NCT01992380

    A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

    Not yet reported Avid Radiopharmaceuticals 24 participants Est. completion 2014-05-30 2 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02016560

    Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects

    Not yet reported, Not yet reported Avid Radiopharmaceuticals 383 participants Est. completion 2017-07-28 27 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Terminated NCT NCT02051764

    Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

    Not yet reported Avid Radiopharmaceuticals 44 participants Est. completion 2016-12 4 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02079766

    18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy

    Not yet reported Avid Radiopharmaceuticals 41 participants Est. completion 2015-10 2 sites
    Other conditions: Chronic Traumatic Encephalopathy
    View official trial listing →
  • Completed NCT NCT02167594

    Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

    Not yet reported Avid Radiopharmaceuticals 29 participants Est. completion 2016-07-11 5 sites
    Other conditions: Progressive Supranuclear Palsy, Corticobasal Degeneration
    View official trial listing →
  • Completed NCT NCT02191267

    Tau Imaging of Chronic Traumatic Encephalopathy

    Not yet reported Brigham and Women's Hospital 30 participants Est. completion 2016-09-30 2 sites
    Other conditions: Chronic Traumatic Encephalopathy
    View official trial listing →
  • Completed NCT NCT02266563

    Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

    Samuel Gandy 46 participants Est. completion 2017-12-21 1 site
    Other conditions: Traumatic Brain Injury, Chronic Traumatic Encephalopathy, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT02278354

    Tau Imaging in Professional Fighters

    Not yet reported Avid Radiopharmaceuticals 35 participants Est. completion 2017-02-03 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02278367

    Clinical Evaluation of Flortaucipir F 18

    Not yet reported Avid Radiopharmaceuticals 179 participants Est. completion 2019-06-26 5 sites
    Other conditions: Alzheimer's Disease, Traumatic Brain Injury, Depression
    View official trial listing →
  • Completed NCT NCT02289118

    Tau Imaging in Young Onset Dementia

    University of Pennsylvania 16 participants Est. completion 2019-01-31 1 site
    Other conditions: Alzheimer's Disease, Early Onset, Logopenic Progressive Aphasia, Posterior Cortical Atrophy (PCA)
    View official trial listing →
  • Completed NCT NCT02336360

    Augmenting Flortaucipir Dosimetry Estimates

    Not yet reported Avid Radiopharmaceuticals 6 participants Est. completion 2015-06 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02350634

    18F-AV-1451 High Resolution Autopsy Study

    Not yet reported Avid Radiopharmaceuticals 3 participants Est. completion 2017-06-16 2 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT02414178

    F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)

    Washington University School of Medicine 130 participants Est. completion 2027-01 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT02414230

    F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis

    Tammie L. S. Benzinger, MD, PhD 9 participants Est. completion 2020-06-10 1 site
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Completed NCT NCT02414282

    F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)

    Tammie L. S. Benzinger, MD, PhD 20 participants Est. completion 2020-10-20 1 site
    Other conditions: Alzheimer Disease, Progressive Posterior Cortical Dysfunction (PPCD)
    View official trial listing →
  • Withdrawn NCT NCT02512029

    18F-AV-1451 PET Imaging in TBI

    Not yet reported Avid Radiopharmaceuticals Est. completion 2017-04 1 site Stand-alone
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT02516046

    18F-AV-1451 Autopsy Study

    Not yet reported Avid Radiopharmaceuticals 156 participants Est. completion 2018-07-15 31 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02676843

    Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

    Not yet reported Columbia University 7 participants Est. completion 2018-11-25 1 site Stand-alone
    Other conditions: Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Tauopathies
    View official trial listing →
  • Withdrawn NCT NCT02707978

    F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)

    Not yet reported Tammie L. S. Benzinger, MD, PhD Est. completion 2020-12-30 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT02736695

    Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia

    Not yet reported Mayo Clinic 81 participants Est. completion 2024-08-01 1 site
    Other conditions: Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant
    View official trial listing →
  • Completed NCT NCT02759887

    Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)

    Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 19 participants Est. completion 2018-12 1 site
    Other conditions: Down Syndrome, Alzheimer's Dementia
    View official trial listing →
  • Terminated NCT NCT02791191

    A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia

    Not yet reported Eli Lilly and Company 316 participants Est. completion 2018-07-02 76 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02795780

    Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

    Not yet reported Avid Radiopharmaceuticals 79 participants Est. completion 2017-08-28 22 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02850146

    18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study

    Not yet reported University of Southern California 55 participants Est. completion 2023-09-29 7 sites Stand-alone
    Other conditions: Cognition Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT02958670

    Imaging Tau Deposition in the Brain of Elderly Subjects

    Not yet reported University of Zurich 141 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment, Healthy, Alzheimer Disease, Neurocognitive Disorders
    View official trial listing →
  • Completed NCT NCT03019536

    A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

    Not yet reported Eli Lilly and Company 22 participants Est. completion 2019-06-05 11 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03040713

    Flortaucipir PET Imaging in Subjects With FTD

    Not yet reported Avid Radiopharmaceuticals 16 participants Est. completion 2018-10-24 3 sites
    Other conditions: Frontotemporal Dementia
    View official trial listing →
  • Terminated NCT NCT03052972

    Flortaucipir 18F PET Imaging in BIOCARD Study

    Not yet reported Avid Radiopharmaceuticals 23 participants Est. completion 2018-08-17 1 site
    Other conditions: Cognitive Decline
    View official trial listing →
  • Active, not recruiting NCT NCT03189485

    Tau PET Imaging in the NACC Study Cohort

    University of Pennsylvania 106 participants Est. completion 2027-05-31 1 site
    Other conditions: Normal Controls, MCI
    View official trial listing →
  • Completed NCT NCT03279523

    F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

    Tammie L. S. Benzinger, MD, PhD 60 participants Est. completion 2018-05-23 1 site
    Other conditions: Alzheimer Disease, HIV
    View official trial listing →
  • Completed NCT NCT03283449

    Tau PET Imaging in Atypical Dementias

    Not yet reported University of Chicago 70 participants Est. completion 2025-02-28 1 site Stand-alone
    Other conditions: Primary Progressive Aphasia With Suspected Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT03287765

    Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans

    Tammie L. S. Benzinger, MD, PhD 54 participants Est. completion 2021-07-19 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03322462

    Tau Screening Study in Patients With Early Symptomatic AD

    Not yet reported Avid Radiopharmaceuticals 155 participants Est. completion 2018-08-31 10 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03467477

    Tau Screening Study in Subjects With Early Symptomatic AD

    Not yet reported Avid Radiopharmaceuticals 161 participants Est. completion 2018-11-15 9 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03507257

    Longitudinal Early-onset Alzheimer's Disease Study Protocol

    Indiana University 850 participants Est. completion 2027-01-01 23 sites
    Other conditions: Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Withdrawn NCT NCT03641768

    Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics

    Not yet reported Duke University Est. completion 2021-01-01 1 site
    Other conditions: Alzheimer Dementia, Posttraumatic Stress Disorder, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT03718494

    Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)

    Mayo Clinic 299 participants Est. completion 2022-09-01 6 sites
    Other conditions: Alzheimer Dementia
    View official trial listing →
  • Withdrawn NCT NCT03816228

    Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.

    Tammie L. S. Benzinger, MD, PhD Est. completion 2022-10-11 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03901092

    A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

    Not yet reported Avid Radiopharmaceuticals 242 participants Est. completion 2019-04-26 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03901105

    Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

    Not yet reported Avid Radiopharmaceuticals 205 participants Est. completion 2019-04-28 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Withdrawn NCT NCT03939780

    Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients

    Not yet reported Johns Hopkins University Est. completion 2023-04 1 site Stand-alone
    Other conditions: Healthy, Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT04080544

    Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study

    Not yet reported Neil M Rofsky, MD, MHA 125 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Alzheimer Disease, Cognitive Decline
    View official trial listing →
  • Completed NCT NCT04417998

    Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction

    Not yet reported Mayo Clinic 80 participants Est. completion 2023-12-20 1 site
    Other conditions: Brain Imaging, Whole Body Imaging
    View official trial listing →
  • Completed NCT NCT04468347

    Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

    Not yet reported Avid Radiopharmaceuticals 89 participants Est. completion 2018-02
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT04474405

    Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

    Not yet reported Avid Radiopharmaceuticals 36 participants Est. completion 2013-12-09 2 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT04680130

    Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

    Mayo Clinic 500 participants Est. completion 2050-11 1 site
    Other conditions: PSP, CBD, PCA, LPA, Semantic Dementia, Semantic Aphasia, Behavioral Variant of Frontotemporal Dementia, FTD, PPA, Apraxia of Speech, MSA - Multiple System Atrophy, Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04926259

    Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders

    Not yet reported First Affiliated Hospital of Fujian Medical University 50 participants Est. completion 2024-12-01 1 site
    Other conditions: Neurodegenerative Disorders
    View official trial listing →
  • Status unknown NCT NCT05326009

    A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease

    Xuanwu Hospital, Beijing 60 participants Est. completion 2023-05-31 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05361382

    Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease

    Not yet reported Tharick Pascoal 822 participants Est. completion 2027-05-31 9 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05393388

    Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study

    University of Pennsylvania 111 participants Est. completion 2027-05 1 site
    Other conditions: Cognitive Decline, Alzheimer Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT05617014

    Alzheimer's Disease Neuroimaging Initiative 4

    University of Southern California 1500 participants Est. completion 2027-07-31 65 sites
    Other conditions: Mild Cognitive Impairment, Alzheimer Disease, Dementia
    View official trial listing →
  • Status unknown NCT NCT05796011

    PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30 participants Est. completion 2024-01-01 1 site
    Other conditions: Age-related Hearing Loss, PET-CT
    View official trial listing →
  • Enrolling by invitation NCT NCT06723015

    Tau PET Outcomes With Anti-amyloid Immunotherapies

    Not yet reported Mayo Clinic 135 participants Est. completion 2028-08 1 site Stand-alone
    Other conditions: Cognitive Impairment, Mild, Dementia, Mild, Alzheimer Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07114224

    Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease

    Not yet reported Xijing Hospital 70 participants Est. completion 2027-06-01
    Other conditions: Alzheimer Disease (AD), Cognitive Dysfunction, Cognitive Disorder, PET Imaging
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.